<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="openVirus\examples\priya950\4-part\PMC7232181\results\search\disease\results.xml">
  <result pre="line of immune defense. In this study, we analyzed whether" exact="influenza" post="A virus (IAV) and/or Staphylococcus aureus (S. aureus) infections"/>
  <result pre="lung, we used a human alveolus-on-a-chip model and a murine" exact="pneumonia" post="model. Our results show that S. aureus can reduce"/>
  <result pre="the lung, which might contribute to a severe outcome of" exact="bacterial pneumonia." post="Staphylococcus aureus pneumonia surfactant protein-A influenza A virus human"/>
  <result pre="contribute to a severe outcome of bacterial pneumonia. Staphylococcus aureus" exact="pneumonia" post="surfactant protein-A influenza A virus human alveolus-on-a-chip 1. Introduction"/>
  <result pre="severe outcome of bacterial pneumonia. Staphylococcus aureus pneumonia surfactant protein-A" exact="influenza" post="A virus human alveolus-on-a-chip 1. Introduction Pneumonia is the"/>
  <result pre="of the lower respiratory tract and also the most common" exact="infectious disease" post="worldwide. A wide variety of microorganisms can induce pneumonia,"/>
  <result pre="microorganisms can induce pneumonia, including viruses and bacteria. Among these," exact="influenza" post="A and B viruses (IAV, IBV) are primary causative"/>
  <result pre="causative agents [1]. The high mortality rates during the large" exact="influenza" post="virus (IV) epidemics and pandemic outbreaks are associated with"/>
  <result pre="ranging from superficial skin infections to life-threatening diseases, such as" exact="bacterial pneumonia" post="[2]. The first line of defense during infections, apart"/>
  <result pre="from superficial skin infections to life-threatening diseases, such as bacterial" exact="pneumonia" post="[2]. The first line of defense during infections, apart"/>
  <result pre="stored at −80 °C. For the murine model, the A/H1N1/pdm09" exact="influenza" post="virus variant HA-D222-mpJena/5258, expressing an aspartate in position 222"/>
  <result pre="from the lung of BALB/c mice infected with the A/H1N1/pdm09" exact="influenza" post="virus isolate A/Jena/5258/09 (kindly provided by Andi Krumbholz [28]."/>
  <result pre="the cell control. 2.5. In Vivo Infection For the murine" exact="pneumonia" post="model the mice were purchased from Janvier Labs (Le"/>
  <result pre="an in vivo murine lung infection model, we established a" exact="pneumonia" post="model and infected the mice with IAV, S. aureus"/>
  <result pre="or independent (IAV infection) on SP-A expression. 4. Discussion Secondary" exact="bacterial pneumonia" post="is one of the main reasons for increased morbidity"/>
  <result pre="independent (IAV infection) on SP-A expression. 4. Discussion Secondary bacterial" exact="pneumonia" post="is one of the main reasons for increased morbidity"/>
  <result pre="surfactant [39]. Early administration of surfactant reduces the risk of" exact="pneumothorax" post="and decreases mortality rates in preterm children [40]. Particularly"/>
  <result pre="the outcome of infants with RDS [41]. Furthermore, the adult" exact="acute respiratory distress syndrome" post="(ARDS) is also associated with a decreased amount of"/>
  <result pre="surfactant phospholipids [42]. In agreement with this result patients with" exact="respiratory failure" post="aggravated by sepsis also had a decreased surfactant level"/>
  <result pre="were found in the bronchoalveolar lavage (BAL) of patients with" exact="pneumonia" post="and without ARDS [44,45]. These examples demonstrate the great"/>
  <result pre="murine model which might contribute to the severe outcome of" exact="bacterial pneumonia." post="Acknowledgments We thank Elke Teuscher for supplying umbilical cords"/>
  <result pre="a potential conflict of interest. References References 1.TaubenbergerJ.K.MorensD.M.The pathology of" exact="influenza" post="virus infectionsAnnu. Rev. Pathol.2008349952210.1146/annurev.pathmechdis.3.121806.15431618039138 2.LowyF.D.Staphylococcus aureus infectionsN. Engl. J."/>
  <result pre="Structure, function and receptorsMol. Immunol.2006431293131510.1016/j.molimm.2005.08.00416213021 8.HanS.MallampalliR.K.The role of surfactant in" exact="lung disease" post="and host defense against pulmonary infectionsAnn. Am. Thorac. Soc.20151276577410.1513/AnnalsATS.201411-507FR25742123"/>
  <result pre="Soc.20151276577410.1513/AnnalsATS.201411-507FR25742123 9.BenneC.A.KraaijeveldC.A.van StrijpJ.A.BrouwerE.HarmsenM.VerhoefJ.van GoldeL.M.van IwaardenJ.F.Interactions of surfactant protein A with" exact="influenza" post="A viruses: Binding and neutralizationJ. Infect. Dis.199517133534110.1093/infdis/171.2.3357844369 10.GeertsmaM.F.NibberingP.H.HaagsmanH.P.DahaM.R.van FurthR.Binding"/>
  <result pre="of Staphylococcus aureus by monocytesAm. J. Physiol.1994267L578L58410.1152/ajplung.1994.267.5.L5787977768 11.BouvierN.M.PaleseP.The biology of" exact="influenza" post="virusesVaccine200826Suppl. S4D49D5310.1016/j.vaccine.2008.07.03919230160 12.HsiehI.N.De LunaX.WhiteM.R.HartshornK.L.The role and molecular mechanism of"/>
  <result pre="action of surfactant protein D in innate host defense against" exact="influenza" post="A virusFront. Immunol.20189136810.3389/fimmu.2018.0136829951070 13.Sever-ChroneosZ.KrupaA.DavisJ.HasanM.YangC.H.SzeligaJ.HerrmannM.HussainM.GeisbrechtB.V.KobzikL.et al.Surfactant protein A (SP-A)-mediated clearance"/>
  <result pre="layers with improved perfusion conditionsBiofabrication2015701501310.1088/1758-5090/7/1/01501325727374 25.Deinhardt-EmmerS.RennertK.SchickeE.CseresnyesZ.WindolphM.NietzscheS.HellerR.SiwczakF.HauptK.F.CarlstedtS.et al.Co-infection withStaphylococcus aureusafter primary" exact="influenza" post="virus infection leads to damage of the endothelium in"/>
  <result pre="222D/G polymorphism facilitates fast intra-host evolution of pandemic (H1N1) 2009" exact="influenza" post="A virusesPLoS ONE20149e10423310.1371/journal.pone.010423325162520 28.ManchandaH.SeidelN.KrumbholzA.SauerbreiA.SchmidtkeM.GuthkeR.Within-host influenza dynamics: A small-scale mathematical"/>
  <result pre="evolution of pandemic (H1N1) 2009 influenza A virusesPLoS ONE20149e10423310.1371/journal.pone.010423325162520 28.ManchandaH.SeidelN.KrumbholzA.SauerbreiA.SchmidtkeM.GuthkeR.Within-host" exact="influenza" post="dynamics: A small-scale mathematical modeling approachBio Syst.2014118515910.1016/j.biosystems.2014.02.004 29.TuchscherrL.MedinaE.HussainM.VolkerW.HeitmannV.NiemannS.HolzingerD.RothJ.ProctorR.A.BeckerK.et al.Staphylococcus"/>
  <result pre="in real-time RT-PCRNucleic Acids Res.200129e4510.1093/nar/29.9.e4511328886 31.BloesD.A.HaasbachE.HartmayerC.HertleinT.KlingelK.KretschmerD.PlanzO.PeschelA.Phenol-soluble modulin peptides contribute to" exact="influenza" post="a virus-associated staphylococcus aureus pneumoniaInfect. Immun.20178510.1128/IAI.00620-1728893917 32.JoshiS.KotechaS.Lung growth and"/>
  <result pre="surfactant protein synthesis in the hypoplastic lung of nitrofen-induced diaphragmatic" exact="hernia" post="in ratsJ. Pediatr. Surg.2000351468147310.1053/jpsu.2000.1641611051153 39.KonishiM.FujiwaraT.NaitoT.TakeuchiY.OgawaY.InukaiK.FujimuraM.NakamuraH.HashimotoT.Surfactant replacement therapy in neonatal"/>
  <result pre="Staphylococcus aureus necrotizing pneumonia: The role of PVL and an" exact="influenza" post="coinfectionExpert Rev. Anti Infect. Ther.2013111041105110.1586/14787210.2013.82789124073746 50.NiemannS.EhrhardtC.MedinaE.WarnkingK.TuchscherrL.HeitmannV.LudwigS.PetersG.LofflerB.Combined action of influenza"/>
  <result pre="an influenza coinfectionExpert Rev. Anti Infect. Ther.2013111041105110.1586/14787210.2013.82789124073746 50.NiemannS.EhrhardtC.MedinaE.WarnkingK.TuchscherrL.HeitmannV.LudwigS.PetersG.LofflerB.Combined action of" exact="influenza" post="virus and Staphylococcus aureus panton-valentine leukocidin provokes severe lung"/>
  <result pre="cellsJ. Virol.2002761071107610.1128/JVI.76.3.1071-1076.200211773383 Figure 1 NCI-H441 cells were productively infected with" exact="influenza" post="A virus (IAV) upon mono- and co-infection with S."/>
  <result pre="human alveolus-on-a-chip model shows SP-A staining (red) of mock infected," exact="influenza" post="virus, S. aureus and co-infected scenarios. Scale bar represents"/>
  <result pre="p &amp;lt; 0.01. Figure 5 Murine model of S. aureus" exact="pneumonia" post="showing viral titers (A) as well as S. aureus"/>
 </snippets>
</snippetsTree>
